Breaking News

You are here » Indian-Commodity  :  Corporate  :  GIPCL signs Power Purchase Agreements with Solar Energy Corporation of India

06-Aug2016

GIPCL signs Power Purchase Agreements with Solar Energy Corporation of India

Gujarat Industries Power Company has signed Power Purchase Agreements with Solar Energy Corporation of India for 2 x 40 MW Solar Power Projects in Gujarat Solar Park, Village Charanka, District Patan, Gujarat under National Solar Mission (NSM) Phase-II, Batch IV.

GIPCL is a Vadodara-based public limited company engaged in the business of power generation with an installed capacity of 815 MW as on March 31, 2015. The company operates two gas based power plants in Vadodara, VS-I and VS-II aggregating 310 MW and two lignite-based power plants in Surat, SLPP-I and SLPP-II aggregating 500 MW.


Related News

View all news

MRF's workers call strike at Tiruvottiyur plant

MRF's workers are on strike at manufacturing plant at Tiruvottiyur near Chennai, since February 2. The strike is illegal and the notice of the strike, including reasons for the same, has not been served......

Linde India reports 62% rise in Q4 net profit

Linde India has reported results for fourth quarter ended December 31, 2018. The company has reported a rise of 61.97% in its net profit at Rs 15.42 crore for the quarter under review as compared to Rs......

Valecha Engineering reports net loss of Rs 15.98 in Q3

Valecha Engineering has reported results for third quarter ended December 31, 2018. The company has reported a net loss of Rs 15.98 crore for the quarter as compared to net loss of Rs 13.19 crore for the......

Top News

View all news

Tata Motors signs LTS agreement with its employees

Tata Motors has signed a long-term wage settlement (LTS) agreement with its employees. Under the agreement, workmen will get a wage rise of Rs 9,000 per month along with other incentives based on performance.......

Canara Bank invites bids from merchant bankers to manage its $350-500 million MTN issue: Report

Canara Bank has reportedly invited bids from merchant bankers to manage its $350-500 million issue of senior unsecured/tier-II capital bonds under its medium-term note (MTN) programme. The issue size may......

Alembic Pharma gets USFDA's nod for Acetazolamide Extended-Release Capsules

Alembic Pharmaceuticals (Alembic) has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Acetazolamide Extended-Release Capsules, 500......